Catecholaminergic gene variants: Contribution in ADHD and associated comorbid attributes in the eastern Indian Probands

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Ghosh, Paramita ^a   Sarkar, Kanyakumarika ^b   Bhaduri, Nipa ^c   Ray, Anirban ^d   Sarkar, Keka ^a   Sinha, Swagata ^a   Mukhopadhyay, Kanchan ^a  

^a Manovikas Biomedical Research and Diagnostic Centre   (India)

^b CT Group of Institutions   (India)

^c Bengal Intelligent Park Building Tower B   (India)

^d MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLYASE; CATECHOL METHYLTRANSFERASE; DNA; DOPAMINE DECARBOXYLASE; DOPAMINE RECEPTOR; DRD2 PROTEIN; DRD4 PROTEIN; UNCLASSIFIED DRUG; AROMATIC LEVO AMINO ACID DECARBOXYLASE; CATECHOLAMINE; COMT PROTEIN, HUMAN; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DRD2 PROTEIN, HUMAN; DRD4 PROTEIN, HUMAN;

ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; CATECHOLAMINERGIC SYSTEM; COMORBIDITY; CONTROLLED STUDY; DNA ISOLATION; DSM-IV-TR; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDIAN; LEUKOCYTE; MAJOR CLINICAL STUDY; ADOLESCENT; ADULT; ASIAN; CASE CONTROL STUDY; CAUCASIAN; CHILD; ENZYMOLOGY; EPISTASIS; FEMALE; GENETICS; INDIA; MALE; PRESCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADOLESCENT; ADULT; AROMATIC-L-AMINO-ACID DECARBOXYLASES; ASIAN CONTINENTAL ANCESTRY GROUP; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; CATECHOLAMINES; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DOPA DECARBOXYLASE; EPISTASIS, GENETIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC VARIATION; HUMANS; INDIA; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; YOUNG ADULT;

EID: 84885611021     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/918410     Document Type: Article

References (72)

1. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders 2000 4th Washington, DC, USA
2. Larson K., Russ S. A., Kahn R. S., Halfon N., Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007. Pediatrics 2011 127 3 462 470 2-s2.0-79952217642 10.1542/peds.2010-0165
3. Lazar J. W., Frank Y., Frontal systems dysfunction in children with attention-deficit/hyperactivity disorder and learning disabilities. Journal of Neuropsychiatry and Clinical Neurosciences 1998 10 2 160 167 2-s2.0-0031778549 (Pubitemid 28241363)
4. Freitag C. M., Retz W., Family and twin studies in attention-deficit hyperactivity disorder. Key Issues in Mental Health 2010 176 38 57 2-s2.0-77956136438 10.1159/000258448
5. Das M., Bhowmik A. D., Bhaduri N., Sarkar K., Ghosh P., Sinha S., Ray A., Chatterjee A., Mukhopadhyay K., Role of gene-gene/gene-environment interaction in the etiology of eastern Indian ADHD probands. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011 35 2 577 587 2-s2.0-79952898576 10.1016/j.pnpbp.2010.12.027
6. DiMaio S., Grizenko N., Joober R., Dopamine genes and attention-deficit hyperactivity disorder: a review. Journal of Psychiatry and Neuroscience 2003 28 1 27 38 2-s2.0-0037223609 (Pubitemid 36315349)
7. Coccaro E. F., Hirsch S. L., Stein M. A., Plasma homovanillic acid correlates inversely with history of learning problems in healthy volunteer and personality disordered subjects. Psychiatry Research 2007 149 1-3 297 302 2-s2.0-33846264918 10.1016/j.psychres.2006.05.009 (Pubitemid 46108112)
8. Civelli O., Bunjow J. R., Grandy D. K., Molecular diversity of the dopamine receptors. Annual Review of Pharmacology and Toxicology 1993 32 281 307 (Pubitemid 23116009)
9. Gingrich J. A., Caron M. G., Recent advances in the molecular biology of dopamine receptors. Annual Review of Neuroscience 1993 16 299 231 2-s2.0-0027533244 (Pubitemid 23074010)
10. Fan X., Xu M., Hess E. J., D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD. Neurobiology of Disease 2010 37 1 228 236 2-s2.0-70449532982 10.1016/j.nbd.2009.10.009
11. Shaw P., Gornick M., Lerch J., Addington A., Seal J., Greenstein D., Sharp W., Evans A., Giedd J. N., Castellanos F. X., Rapoport J. L., Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder. Archives of General Psychiatry 2007 64 8 921 931 2-s2.0-34547750487 10.1001/archpsyc.64.8.921 (Pubitemid 47230616)
12. Bhaduri N., Das M., Sinha S., Chattopadhyay A., Gangopadhyay P. K., Chaudhuri K., Singh M., Mukhopadhyay K., Association of dopamine D4 receptor (DRD4) polymorphisms with attention deficit hyperactivity disorder in Indian population. American Journal of Medical Genetics B 2006 141 1 61 66 2-s2.0-30344459668 10.1002/ajmg.b.30225 (Pubitemid 43062544)
13. Kereszturi E., Kiraly O., Csapo Z., Tarnok Z., Gadoros J., Sasvari-Szekely M., Nemoda Z., Association between the 120-bp duplication of the dopamine D4 receptor gene and attention deficit hyperactivity disorder: genetic and molecular analyses. American Journal of Medical Genetics B 2007 144 2 231 236 2-s2.0-34047244351 10.1002/ajmg.b.30444 (Pubitemid 46606649)
14. McCracken J. T., Smalley S. L., McGough J. J., Crawford L., Del'Homme M., Cantor R. M., Liu A., Nelson S. F., Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with attention deficit hyperactivity disorder (ADHD). Molecular Psychiatry 2000 5 5 531 536 2-s2.0-0033804337
15. Banaschewski T., Becker K., Scherag S., Franke B., Coghill D., Molecular genetics of attention-deficit/hyperactivity disorder: an overview. European Child and Adolescent Psychiatry 2010 19 3 237 257 2-s2.0-77950859536 10.1007/s00787-010-0090-z
16. Waldman I. D., Gizer I. R., The genetics of attention deficit hyperactivity disorder. Clinical Psychology Review 2006 26 4 396 432 2-s2.0-33745685846 10.1016/j.cpr.2006.01.007
17. Mick E., Faraone S. V., Genetics of attention deficit hyperactivity disorder. Child and Adolescent Psychiatric Clinics of North America 2008 17 2 261 284 2-s2.0-39449133654 10.1016/j.chc.2007.11.011 (Pubitemid 351265400)
18. Guan L., Wang B., Chen Y., Yang L., Li J., Qian Q., Wang Z., Faraone S. V., Wang Y., A high-density single-nucleotide polymorphism screen of 23 candidate genes in attention deficit hyperactivity disorder: suggesting multiple susceptibility genes among Chinese Han population. Molecular Psychiatry 2009 14 5 546 554 2-s2.0-65349083740 10.1038/sj.mp.4002139
19. Carpentier P. J., Arias Vasquez A., Hoogman M., Onnink M., Kan C. C., Kooij J. J., Makkinje R., Iskandar S., Kiemeney L. A., de Jong C. A., Franke B., Buitelaar J. K., Shared and unique genetic contributions to attention deficit/hyperactivity disorder and substance use disorders: a pilot study of six candidate genes. European Neuropsychopharmacology 2013 23 448 457
20. Hawi Z., Matthews N., Barry E., Kirley A., Wagner J., Wallace R. H., Heussler H. S., Vance A., Gill M., Bellgrove M. A., A high density linkage disequilibrium mapping in 14 noradrenergic genes: evidence of association between SLC6A2, ADRA1B and ADHD. Psychopharmacology (Berl) 2013 225 895 902
21. Lasky-Su J., Neale B. M., Franke B., Anney R. J. L., Zhou K., Maller J. B., Vasquez A. A., Chen W., Asherson P., Buitelaar J., Banaschewski T., Ebstein R., Gill M., Miranda A., Mulas F., Oades R. D., Roeyers H., Rothenberger A., Sergeant J., Sonuga-Barke E., Steinhausen H. C., Taylor E., Daly M., Laird N., Lange C., Faraone S. V., Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. American Journal of Medical Genetics B 2008 147 8 1345 1354 2-s2.0-57349087863 10.1002/ajmg.b.30867
22. Ribasés M., Ramos-Quiroga J. A., Hervás A., Bosch R., Bielsa A., Gastaminza X., Artigas J., Rodriguez-Ben S., Estivill X., Casas M., Cormand B., Bayés M., Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB. Molecular Psychiatry 2009 14 1 71 85 2-s2.0-58049204451 10.1038/sj.mp.4002100
23. Qian Q.-J., Liu J., Wang Y.-F., Yang L., Guan L.-L., Faraone S. V., Attention deficit hyperactivity disorder comorbid oppositional defiant disorder and its predominately inattentive type: evidence for an association with COMT but not MAOA in a Chinese sample. Behavioral and Brain Functions 2009 5 article 8 2-s2.0-63649155693 10.1186/1744-9081-5-8
24. Comings D. E., Gade-Andavolu R., Gonzalez N., Wu S., Muhleman D., Blake H., Dietz G., Saucier G., MacMurray J. P., Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 20 genes. Clinical Genetics 2000 57 3 178 196 2-s2.0-0034108482 10.1034/j.1399-0004.2000.570304.x (Pubitemid 30168746)
25. Kirley A., Hawi Z., Daly G., McCarron M., Mullins C., Millar N., Waldman I., Fitzgerald M., Gill M., Dopaminergic system genes in ADHD: toward a biological hypothesis. Neuropsychopharmacology 2002 27 4 607 619 2-s2.0-0036788707 10.1016/S0893-133X(02)00315-9
26. Nyman E. S., Ogdie M. N., Loukola A., Varilo T., Taanila A., Hurtig T., Moilanen I. K., Loo S. K., McGough J. J., Järvelin M.-R., Smalley S. L., Nelson S. F., Peltonen L., ADHD candidate gene study in a population-based birth cohort: association with DBH and DRD2. Journal of the American Academy of Child and Adolescent Psychiatry 2007 46 12 1614 1621 2-s2.0-36348945172 10.1097/chi.0b013e3181579682 (Pubitemid 350146526)
27. Michaelovsky E., Gothelf D., Korostishevsky M., Frisch A., Burg M., Carmel M., Steinberg T., Inbar D., Apter A., Weizman A., Association between a common haplotype in the COMT gene region and psychiatric disorders in individuals with 22q11.2DS. International Journal of Neuropsychopharmacology 2008 11 3 351 363 2-s2.0-41649100270 10.1017/S1461145707008085 (Pubitemid 351482504)
28. Wu J., Xiao H., Sun H., Zou L., Zhu L. Q., Role of dopamine receptors in ADHD: a systematic meta-analysis. Molecular Neurobiology 2012 45 605 620
29. Zhang H., Ye Y., Wang X., Gelernter J., Ma J. Z., Li M. D., DOPA decarboxylase gene is associated with nicotine dependence. Pharmacogenomics 2006 7 8 1159 1166 2-s2.0-33845904424 10.2217/14622416.7.8.1159 (Pubitemid 46024179)
30. Prasad P., Ambekar A., Vaswani M., Dopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males: a preliminary study. BMC Medical Genetics 2010 11 1, article 24 2-s2.0-77649157894 10.1186/1471-2350-11- 24
31. Conners C. K., Conners' Rating Scales-Revised Multi-Health Systems 1997 Toronto, Canada
32. Wechsler D., Wechsler Intelligence Scale for Children: Manual 1991 3rd San Antonio, Tex, USA Psychological Corporation
33. Bharat Raj J., AIISH norms on SFB with Indian children. Journal of All India Institute of Speech and Hearing 1971 2 34 39
34. Miller S. A., Dykes D. D., Polesky H. F., A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 1988 16 3 1215 2-s2.0-0024284028 10.1093/nar/16.3.1215
35. Dudbridge F., Pedigree disequilibrium tests for multilocus haplotypes. Genetic Epidemiology 2003 25 2 115 121 2-s2.0-0041857847 10.1002/gepi.10252 (Pubitemid 37064867)
36. Spielman R. S., McGinnis R. E., Ewens W. J., Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). American Journal of Human Genetics 1993 52 3 506 516 2-s2.0-0027377799 (Pubitemid 23311321)
37. Terwilliger J. D., Ott J., A haplotype-based "Haplotype Relative Risk" approach to detecting allelic associations. Human Heredity 1992 42 6 337 346 2-s2.0-0026494911
38. Lenth R. V., Statistical power calculations. Journal of animal science 2007 85 13 E24 E29 2-s2.0-34548032852 10.2527/jas.2006-449
39. Moore J. H., Gilbert J. C., Tsai C.-T., Chiang F.-T., Holden T., Barney N., White B. C., A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. Journal of Theoretical Biology 2006 241 2 252 261 2-s2.0-33745599582 10.1016/j.jtbi.2005.11.036 (Pubitemid 43993963)
40. Moore J. H., White B. C., Tuning relief for genome-wide genetic analysis. Evolutionary Computation,Machine Learning and Data Mining in Bioinformatics 2007 4447 Berlin, Germany Springer 166 175 Lecture Notes in Computer Science 10.1007/978-3-540-71783-6-16
41. Ritchie M. D., Hahn L. W., Roodi N., Bailey L. R., Dupont W. D., Parl F. F., Moore J. H., Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. American Journal of Human Genetics 2001 69 1 138 147 2-s2.0-0034973569 10.1086/321276 (Pubitemid 32614026)
42. Hahn L. W., Ritchie M. D., Moore J. H., Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003 19 3 376 382 2-s2.0-0037433052 10.1093/bioinformatics/btf869 (Pubitemid 36284937)
43. Mei H., Cuccaro M. L., Martin E. R., Multifactor dimensionality reduction-phenomics: a novel method to capture genetic heterogeneity with use of phenotypic variables. American Journal of Human Genetics 2007 81 6 1251 1261 2-s2.0-36749015065 10.1086/522307 (Pubitemid 350211453)
44. Martin E. R., Ritchie M. D., Hahn L., Kang S., Moore J. H., A novel method to identify gene-gene effects in nuclear families: the MDR-PDT. Genetic Epidemiology 2006 30 2 111 123 2-s2.0-32044462757 10.1002/gepi.20128 (Pubitemid 43201584)
45. Thapar A., Harrington R., McGuffin P., Examining the comorbidity of ADHD-related behaviours and conduct problems using a twin study design. British Journal of Psychiatry 2001 179 224 229 2-s2.0-0034843635 10.1192/bjp.179.3.224 (Pubitemid 32844283)
46. 18F]DOPA accumulation in children with attention deficit hyperactivity disorder. American Journal of Psychiatry 1999 156 8 1209 1215 2-s2.0-0032587158 (Pubitemid 29374881)
47. Parsons M. J., Mata I., Beperet M., Iribarren-Iriso F., Arroyo B., Sainz R., Arranz M. J., Kerwin R., A dopamine D2 receptor gene-related polymorphism is associated with schizophrenia in a Spanish population isolate. Psychiatric Genetics 2007 17 3 159 163 2-s2.0-34248151448 10.1097/YPG.0b013e328017f8a4 (Pubitemid 46716208)
48. AL-Eitan L. N., Jaradat S. A., Hulse G. K., Tay G. K., Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent. BMC Research Notes 2012 5 article 497
49. Cravchik A., Sibley D. R., Gejman P. V., Functional analysis of the human D2 dopamine receptor missense variants. Journal of Biological Chemistry 1996 271 42 26013 26017 2-s2.0-0029860139 10.1074/jbc.271.42.26013 (Pubitemid 26347439)
50. Doehring A., Kirchhof A., Lötsch J., Genetic diagnostics of functional variants of the human dopamine D2 receptor gene. Psychiatric genetics 2009 19 5 259 268 2-s2.0-76249087239
51. Todd R. D., Lobos E. A., Mutation screening of the dopamine D2 receptor gene in attention-deficit hyperactivity disorder subtypes: preliminary report of a research strategy. American Journal of Medical Genetics B 2002 114 1 34 41 2-s2.0-70349915978 10.1002/ajmg.1619 (Pubitemid 34027577)
52. Arinami T., Gao M., Hamaguchi H., Toru M., A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Human Molecular Genetics 1997 6 4 577 582 2-s2.0-0030933979 10.1093/hmg/6.4.577 (Pubitemid 27142107)
53. Arranz M. J., De Leon J., Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research. Molecular Psychiatry 2007 12 8 707 747 2-s2.0-34547469943 10.1038/sj.mp.4002009 (Pubitemid 47172693)
54. Zhang J.-P., Lencz T., Malhotra A. K., D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis. American Journal of Psychiatry 2010 167 7 763 772 2-s2.0-77954224633 10.1176/appi.ajp. 2009.09040598
55. Sánchez-Mora C., Ribasés M., Casas M., Bayés M., Bosch R., Fernàndez-Castillo N., Brunso L., Jacobsen K. K., Landaas E. T., Lundervold A. J., Gross-Lesch S., Kreiker S., Jacob C. P., Lesch K.-P., Buitelaar J. K., Hoogman M., Kiemeney L. A. L. M., Kooij J. J. S., Mick E., Asherson P., Faraone S. V., Franke B., Reif A., Johansson S., Haavik J., Ramos-Quiroga J. A., Cormand B., Exploring DRD4 and its interaction with SLC6A3 as possible risk factors for adult ADHD: a meta-analysis in four European populations. American Journal of Medical Genetics B 2011 156 5 600 612 2-s2.0-79958742968 10.1002/ajmg.b.31202
56. Kustanovich V., Ishii J., Crawford L., Yang M., McGough J. J., McCracken J. T., Smalley S. L., Nelson S. F., Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5. Molecular Psychiatry 2004 9 7 711 717 2-s2.0-3142773314 (Pubitemid 38932176)
57. Brookes K.-J., Xu X., Chen C.-K., Huang Y.-S., Wu Y.-Y., Asherson P., No evidence for the association of DRD4 with ADHD in a Taiwanese population within-family study. BMC Medical Genetics 2005 6 article 31 2-s2.0-26444584570 10.1186/1471-2350-6-31 (Pubitemid 41418988)
58. Seeman P., Ulpian C., Chouinard G., Van Tol H. H. M., Dwosh H., Lieberman J. A., Siminovitch K., Liu I. S. C., Waye J., Voruganti P., Hudson C., Serjeant G. R., Masibay A. S., Seeman M. V., Dopamine D4 receptor variant, D4GLYCINE194, in Africans, but not in Caucasians: no association with schizophrenia. American Journal of Medical Genetics 1994 54 4 384 390 2-s2.0-0028673978 10.1002/ajmg.1320540419
59. Catalano M., Nobile M., Novelli E., Nothen M. M., Smeraldi E., Distribution of a novel mutation in the first exon of the human dopamine D4 receptor gene in psychotic patients. Biological Psychiatry 1993 34 7 459 464 2-s2.0-0027484743 10.1016/0006-3223(93)90236-7 (Pubitemid 23337728)
60. Cheuk D. K. L., Wong V., Meta-analysis of association between a catechol-O-methyltransferase gene polymorphism and attention deficit hyperactivity disorder. Behavior Genetics 2006 36 5 651 659 2-s2.0-33746895813 10.1007/s10519-006-9076-5 (Pubitemid 44188080)
61. Beuten J., Payne T. J., Ma J. Z., Li M. D., Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations. Neuropsychopharmacology 2006 31 3 675 684 2-s2.0-33244492833 10.1038/sj.npp.1300997 (Pubitemid 43276983)
62. Bray N. J., Buckland P. R., Williams N. M., Williams H. J., Norton N., Owen M. J., O'Donovan M. C., A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. American Journal of Human Genetics 2003 73 1 152 161 2-s2.0-0038389841 10.1086/376578 (Pubitemid 36793787)
63. Turic D., Williams H., Langley K., Owen M., Thapar A., O'Donovan M. C., A family based study of catechol-O-methyltransferase (COMT) and Attention Deficit Hyperactivity Disorder (ADHD). American Journal of Medical Genetics B 2005 133 1 64 67 2-s2.0-12944312690 10.1002/ajmg.b.30123 (Pubitemid 40175617)
64. Hettema J. M., An S.-S., Bukszar J., van den Oord E. J. C. G., Neale M. C., Kendler K. S., Chen X., Catechol-O-methyltransferase contributes to genetic susceptibility shared among anxiety spectrum phenotypes. Biological Psychiatry 2008 64 4 302 310 2-s2.0-48149100091 10.1016/j.biopsych.2008.03.014
65. Karayiorgou M., Sobin C., Blundell M. L., Galke B. L., Malinova L., Goldberg P., Ott J., Gogos J. A., Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biological Psychiatry 1999 45 9 1178 1189 2-s2.0-0033135862 10.1016/S0006-3223(98)00319-9 (Pubitemid 29236559)
66. Halleland H., Lundervold A. J., Halmøy A., Haavik J., Johansson S., Association between catechol O-methyltransferase [COMT] haplotypes and severity of hyperactivity symptoms in adults. American Journal of Medical Genetics B 2009 150 3 403 410 2-s2.0-63449100481 10.1002/ajmg.b.30831
67. Bidwell L. C., Garrett M. E., McClernon F. J., Fuemmeler B. F., Williams R. B., Ashley-Koch A. E., Kollins S. H., A preliminary analysis of interactions between genotype, retrospective ADHD symptoms, and initial reactions to smoking in a sample of young adults. Nicotine and Tobacco Research 2012 14 2 229 233 2-s2.0-84856395703 10.1093/ntr/ntr125
68. Beaver K. M., Wright J. P., DeLisi M., Walsh A., Vaughn M. G., Boisvert D., Vaske J., A gene × gene interaction between DRD2 and DRD4 is associated with conduct disorder and antisocial behavior in males. Behavioral and Brain Functions 2007 3 article 30 2-s2.0-34547615219 10.1186/1744-9081-3-30 (Pubitemid 47202108)
69. Heinzel S., Dresler T., Baehne C. G., Heine M., Boreatti-Hümmer A., Jacob C. P., Renner T. J., Reif A., Lesch K. P., Fallgatter A. J., Ehlis A. C., COMT×DRD4 epistasis impacts prefrontal cortex function underlying response control. Cerebral Cortex 2013 23 1453 1462
70. Xu H., Kellendonk C. B., Simpson E. H., Keilp J. G., Bruder G. E., Polan H. J., Kandel E. R., Gilliam T. C., DRD2 C957T polymorphism interacts with the COMT Val158Met polymorphism in human working memory ability. Schizophrenia Research 2007 90 1-3 104 107 2-s2.0-33846563391 10.1016/j.schres.2006.10.001 (Pubitemid 46177561)
71. Harrison P. J., Weinberger D. R., Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry 2005 10 1 40 68 2-s2.0-12344327212 10.1038/sj.mp.4001558 (Pubitemid 40139588)
72. Kellendonk C., Simpson E. H., Polan H. J., Malleret G., Vronskaya S., Winiger V., Moore H., Kandel E. R., Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 2006 49 4 603 615 2-s2.0-32344435859 10.1016/j.neuron.2006.01.023 (Pubitemid 43221894)